IMU-838

Immunic's lead drug fails to impress in 2 separate trials — and it's blaming some of its woes on the pandemic
Endpoints
Thu, 02/18/21 - 09:48 pm
Immunic
clinical trials
pandemic
COVID-19
primary sclerosing cholangitis
IMU-838
Immunic's lead MS drug hits primary and key secondary endpoints in PhII, but questions remain
Endpoints
Mon, 08/3/20 - 10:22 am
Immunic
MS
multiple sclerosis
clinical trials
IMU-838